Business

ESTRO 2025 Congress: GE HealthCare to expand its radiation oncology portfolio and introduce new AI-enabled solutions

CHICAGO, May 02, 2025--GE HealthCare (Nasdaq: GEHC) today announced an intended expansion of its radiation oncology portfolio as well as the introduction of the new AI-enabled MR Contour DL™ at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2025 Congress in Vienna, Austria. The company will also showcase its updated Intelligent Radiation Therapy (iRT), a software solution that standardizes complex workflows, helping to enable a shorter timeline from diagnosis to treatment an

articleGe Healthcare Technologies Inc.May 2, 20256/company/ge-healthcare-technologies-inc/news/estro-2025-congress-ge-healthcare-to-expand-its-radiation-oncology-portfolio-and-introduce-new-ai-enabled-solutions
ESTRO 2025 Congress: GE HealthCare to expand its radiation oncology portfolio and introduce new AI-enabled solutions

About this update from Ge Healthcare Technologies Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":6570,"height":2242,"url":"https://media.zenfs.com/en/business-wire.com/326fdd67a31dd726a21b676cea0868a0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/35hGZgcJVt2UrdNuMGB_kQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMyODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/326fdd67a31dd726a21b676cea0868a0","width":960,"height":328},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/j3zNkhHBtUZZ2c1EeQVSPQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04MTg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/326fdd67a31dd726a21b676cea0868a0","width":1200,"height":409}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"The company will showcase innovations designed to optimize the oncology care workflow and enable improved patient outcomes","length":122,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":122,"olType":false},{"type":"text","content":"CHICAGO, May 02, 2025--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced an intended expansion of its radiation oncology portfolio as well as the introduction of the new AI-enabled MR Contour DL™ at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2025 Congress in Vienna, Austria. The company will also showcase its updated Intelligent Radiation Therapy (iRT), a software solution that standardizes complex workflows, helping to enable a shorter timeline from diagnosis to treatment and more precise radiation therapy.","length":550,"tagName":"p"},{"type":"text","content":"According to the World Health Organization (WHO), cancer continues to be a leading cause of death worldwide, accounting for nearly ten million deaths per year.i However, it is estimated that approximately one-third of these lives could be saved if cancer is detected and treated early.ii GE HealthCare's solutions featured at ESTRO aim to empower healthcare professionals with advanced tools and technologies to deliver more precise care, improve timeliness and efficiency, and enhance patient outcomes.","length":507,"tagName":"p"},{"type":"text","content":"A radiation oncology portfolio that is poised to enable more timely and precise patient care","length":92,"tagName":"p"},{"type":"text","content":"GE HealthCare inten...

More updates from Ge Healthcare Technologies Inc.

GE HealthCareradiation oncologyWorld Health OrganizationESTROSpectronicSpectronic Medical